These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24748523)

  • 1. Pertussis vaccine performance in an epidemic year-Oregon, 2012.
    Liko J; Robison SG; Cieslak PR
    Clin Infect Dis; 2014 Jul; 59(2):261-3. PubMed ID: 24748523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinated children and adolescents with pertussis infections experience reduced illness severity and duration, Oregon, 2010-2012.
    Barlow RS; Reynolds LE; Cieslak PR; Sullivan AD
    Clin Infect Dis; 2014 Jun; 58(11):1523-9. PubMed ID: 24633685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Pertussis Vaccines Protect Against Bordetella parapertussis?
    Liko J; Robison SG; Cieslak PR
    Clin Infect Dis; 2017 Jun; 64(12):1795-1797. PubMed ID: 28369240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of additional pertussis vaccine doses on disease incidence in children and infants.
    Stein-Zamir C; Shoob H; Abramson N; Zentner G
    Vaccine; 2010 Dec; 29(2):207-11. PubMed ID: 21055497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?
    van der Maas NA; Mooi FR; de Greeff SC; Berbers GA; Spaendonck MA; de Melker HE
    Vaccine; 2013 Sep; 31(41):4541-7. PubMed ID: 23933365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why do pertussis vaccines fail?
    Cherry JD
    Pediatrics; 2012 May; 129(5):968-70. PubMed ID: 22529282
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of epidemics of vaccine-preventable disease on vaccine uptake: lessons from the 2011-2012 US pertussis epidemic.
    Wolf ER; Rowhani-Rahbar A; Opel DJ
    Expert Rev Vaccines; 2015 Jul; 14(7):923-33. PubMed ID: 25872609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis (whooping cough) epidemiology in Waikato, New Zealand: 2000-2009.
    Wall R; Bell A; Theobald J
    N Z Med J; 2011 Apr; 124(1332):52-61. PubMed ID: 21747424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming with whole-cell versus acellular pertussis vaccine.
    Liko J; Robison SG; Cieslak PR
    N Engl J Med; 2013 Feb; 368(6):581-2. PubMed ID: 23388023
    [No Abstract]   [Full Text] [Related]  

  • 10. The 1996 pertussis epidemic in New Zealand: descriptive epidemiology.
    Blakely T; Mansoor O; Baker M
    N Z Med J; 1999 Feb; 112(1081):30-3. PubMed ID: 10078212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waning immunity to pertussis following 5 doses of DTaP.
    Tartof SY; Lewis M; Kenyon C; White K; Osborn A; Liko J; Zell E; Martin S; Messonnier NE; Clark TA; Skoff TH
    Pediatrics; 2013 Apr; 131(4):e1047-52. PubMed ID: 23478868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.
    Thierry-Carstensen B; Dalby T; Stevner MA; Robbins JB; Schneerson R; Trollfors B
    Vaccine; 2013 Oct; 31(45):5178-91. PubMed ID: 23994021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Problems of whooping cough not yet solved. Epidemiology and vaccination strategy in Germany--country-wide field study].
    Schneeweiss B; Swidsinski S
    Fortschr Med; 1997 Aug; 115(24):28-30. PubMed ID: 9410816
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of an acellular pertussis vaccine among adolescents and adults.
    Ward JI; Cherry JD; Chang SJ; Partridge S; Lee H; Treanor J; Greenberg DP; Keitel W; Barenkamp S; Bernstein DI; Edelman R; Edwards K;
    N Engl J Med; 2005 Oct; 353(15):1555-63. PubMed ID: 16221778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology.
    Sheridan SL; Frith K; Snelling TL; Grimwood K; McIntyre PB; Lambert SB
    Expert Rev Vaccines; 2014 Sep; 13(9):1081-106. PubMed ID: 25093268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis vaccines: where to now?
    Poolman JT; Hallander H; Halperin SA
    Expert Rev Vaccines; 2011 Nov; 10(11):1497-500. PubMed ID: 22043947
    [No Abstract]   [Full Text] [Related]  

  • 17. Pertussis-the case for universal vaccination.
    Rittle C
    J Spec Pediatr Nurs; 2010 Oct; 15(4):282-91. PubMed ID: 20880276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.
    Witt MA; Katz PH; Witt DJ
    Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Timing of Pertussis Cases in Unvaccinated Children in an Outbreak Year: Oregon 2012.
    Robison SG; Liko J
    J Pediatr; 2017 Apr; 183():159-163. PubMed ID: 28088399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of an accelerated immunisation schedule on pertussis in England and Wales.
    White JM; Fairley CK; Owen D; Matthews RC; Miller E
    Commun Dis Rep CDR Rev; 1996 May; 6(6):R86-91. PubMed ID: 8664929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.